AstraZeneca Can't Stop Generic Diabetes Drug Launch

AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop...

Already a subscriber? Click here to view full article